Predicting childbirth PTSD after unplanned cesarean using early postpartum screening

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study investigates if early postpartum screening tools can identify individuals at risk for childbirth-related PTSD after an unplanned cesarean delivery. Participants complete the Peritraumatic Distress Inventory, City BiTS-SF, and EPDS within 24-48 hours after birth, with follow-up assessments at 6 weeks and 3 months using the PCL-5 and EPDS. The study aims to determine the predictive value and diagnostic performance of these tools, and to assess feasibility of routine psychological birth trauma screening in the immediate postpartum period. Primary goal is to see if early PDI and CityBiTS-SF scores predict CB-PTSD at 6 weeks; secondary analyses examine associations with depressive symptoms and practicality of implementation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥19 years
* Underwent unplanned cesarean delivery
* Able to provide informed consent
* Able to read and understand English questionnaires

Exclusion Criteria:

* Fetal or neonatal demise
* Unable to complete study questionnaires or provide informed consent

Where it's running

• BC Women's Hospital and Health Centre
  Vancouver, British Columbia, Canada Recruiting

Study contacts

• Study coordinator: Katherine Seligman, MD
• Email: katie.seligman@cw.bc.ca
• Phone: 604-875-2158

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Anger, Social Thinking, and PTSD in French Veterans

  This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

  Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

• TSND-201 treatment for PTSD in adults

  This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

  Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

• Brexanolone therapy for moms with postpartum depression

  This trial tests LPCN 1154A against placebo to see if it can help reduce depression symptoms in women with severe postpartum depression.

  Recruiting at 16 sites Phase 3 Lipocine Inc. · Tucson, Arizona and 15 other locations · NCT07822321

• Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

  This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

• SEE FAR CBT for Adults With PTSD

  This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.

  Recruiting Community Stress Prevention Center · Kiryat Shmona · NCT07720674

• Brief SEE FAR CBT: a short, focused therapy for adults with PTSD

  A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.

  Recruiting Community Stress Prevention Center · Sha'ar Hanegev · NCT07710573

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.